Medikamentenvergleiche
Insulin Regular Human vs. Repaglinide
Compare regular insulin vs repaglinide for type 2 diabetes. Insulin is injectable short-acting, repaglinide is oral meglitinide stimulating insulin release.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
This comparison arises for type 2 diabetes patients considering meglitinide therapy versus starting insulin.
Fazit
Insulin is more versatile and preferred for broader use while repaglinide offers convenient oral dosing with meal-related action.
Alle Medikamentenvergleiche